Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Lumiata logo — In 2022, Lumiata's assets were acquired by Somatus, the nati...

Lumiata

In 2022, Lumiata's assets were acquired by Somatus, the nation’s leading and largest value-based kidney care company.

Founded 2013 United States San Mateo, United States 3 employees Acquired Total: $45.00M AI, Analytics +2

General Information

Company Name Lumiata
Founded Year 2013
Location United States San Mateo, United States
Employees 3
Industries AI, Analytics, Health Care +1
Funding Stage Acquired
Business Model B2B, SaaS, Platform
Revenue Model Value Based Pricing, Subscription, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Lumiata. To contact Lumiata, visit lumiata.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Lumiata compare?

A PDF of Lumiata and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Lumiata soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Lumiata

Lumiata, founded in 2013 and headquartered in the United States, specialized in the intersection of AI, Analytics, Health Care, and Machine Learning. The company's technological prowess in these sectors attracted notable attention in the investment community.

In its most recent funding round, Lumiata raised a $14.00M Series B investment on January 14, 2021, with contributions from prominent investors such as Khosla Ventures, Allegis Capital, Defy.vc, and Castor Ventures. This underlined the market's confidence in Lumiata's innovative capabilities and growth trajectory.

However, in 2022, Lumiata's assets were acquired by Somatus, a leader in value-based kidney care. This acquisition marks a strategic consolidation in the healthcare analytics field, potentially leveraging Lumiata's AI technologies to enhance Somatus's offerings, solidifying its position as the largest in its domain.

Business keywords: healthcare analytics, value-based care, kidney care, acquisition, healthcare industry, medical data

Services & Products

Individualized Clinical Support
Emotional and Social Support
Patient Portal
Provider Portal
Health Plan Partnerships

Target Customers

Patients with Kidney and Heart Conditions Healthcare Providers Health Plans Caregivers

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition Undisclosed 1
Somatus
01 Apr 2022
Series B $14.00M 5
Blue Venture Fund Khosla Ventures Defy Partners
Blue Venture Fund, Khosla Ventures +3
01 Jan 2021
Series B $11.00M 5
Blue Venture Fund Khosla Ventures Intel Capital
Blue Venture Fund, Khosla Ventures +3
01 Jul 2018
Seed Undisclosed 2
Castor Ventures, Alumni Ventures
01 Nov 2017
Series B $10.00M 4
Khosla Ventures Intel Capital
Khosla Ventures, Intel Capital +2
01 May 2016
Series A $6.00M 2
BlueCross BlueShield Venture Partners, Sandbox Industries
01 Sep 2014
Series A $4.00M 1
Khosla Ventures
Khosla Ventures
01 Jan 2014
Early VC Undisclosed 1
Khosla Ventures
Khosla Ventures
01 Jul 2013

Lumiata Alternatives & Competitors

View All Alternatives
Lumiata vs
Cedar Gate Technologies
Cedar Gate Technologies United States

Empowering Payers, Providers, and Employers/ASOs to Excel at Value-Based Care

Private Equity
1132 employees
Analytics, Health Care
Lumiata vs
Precision Health AI
Precision Health AI

Harnessing AI for Next-Level Oncology Solutions and Value-Based Care

Series A
AI, Biotechnology
Lumiata vs
NextGen Healthcare India
NextGen Healthcare India India

NextGen Healthcare is the technology partner for diverse ambulatory practices with evolving business...

Venture round
175 employees
Analytics, Digital Health
View all alternatives

FAQ About Lumiata

In 2022, Lumiata's assets were acquired by Somatus, the nation’s leading and largest value-based kidney care company.
Lumiata was founded in 2013.
Lumiata is headquartered in San Mateo, United States.
Lumiata operates in AI, Analytics, Health Care and Machine Learning. Its work centres on healthcare analytics, value-based care, kidney care and acquisition. Its customers include Patients with Kidney and Heart Conditions, Healthcare Providers and Health Plans.
Lumiata has a B2B, SaaS and Platform business model. Its revenue comes from Value Based Pricing, Subscription and Service Fee.
Lumiata has approximately 3 employees.
Lumiata has completed 8 funding rounds, raising a total of $45.00M. The latest funding stage is Acquired.
Lumiata offers: Individualized Clinical Support, Emotional and Social Support, Patient Portal, Provider Portal, Health Plan Partnerships.
Top alternatives and competitors to Lumiata include Cedar Gate Technologies, Precision Health AI, NextGen Healthcare India, Humedica, Clarify Health Solutions. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lumiata and Cedar Gate Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Lumiata, https://bouncewatch.com/company/lumiata, updated 22 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes